CardioSource WorldNews | Page 22

CLINICAL

NEWS
TELE-HEALTH READY MADE FOR
CVD
We mentioned tele-health in passing.
In June 2016, the Agency for Healthcare Research and Quality released a
report indicating that the top chronic
conditions for telehealth success were
cardiovascular disease (CVD) and respiratory disease. Investigators conducted
a systematic review and found “a large,
broad evidence base about the effectiveness of telehealth, including over 200
systematic reviews and hundreds of primary studies published since 2006.”4
They identified a substantial amount
of evidence, including 58 systematic
reviews that covered several important clinical focus areas and met their
inclusion criteria.
Twelve reviews covered CVD and an
additional eight dealt with diabetes.
The former included studies of telehealth for the management of heart
failure, acute care and follow-up for
myocardial infarction, management
of patients with implantable defibrillators, and primary and secondary
prevention of coronary disease; the
latter included management of type
1, type 2, and gestational diabetes
and a target range of activities from
regulating glucose levels to promoting
physical activity.
CVD/remote patient monitoring
had the most evidence followed by
psychotherapy and behavioral health.
The most consistent benefit for telehealth has been for communication
and counseling or remote monitoring
in chronic conditions such as cardiovascular and respiratory disease, with
improvements in outcomes such as
mortality, quality of life, and reductions in hospital admissions.
Given sufficient evidence of effectiveness for these topics, the report
concludes that future research should
shift to implementation and practicebased research. ■

American College of Cardiology Extended Learning

Take-aways
• With the $3 trillion health care industry moving more towards
consumer choice, patients are being asked to assume more
responsibility for managing their own care as well as take a
more active role in their overall health and wellness.
• In response, insurers and health care companies are rolling

out new products and services that empower patients, but
there is a disconnect between what’s being offered and what
patients want in terms of digital (or mHealth) resources.
• A new government report finds that cardiovascular disease
has the most evidence to support the use of tele-health
to improve outcomes such as mortality, quality of life, and
reductions in hospital admissions.

PUT EFFIENT (PRASUGREL)
IN HIS CORNER
®

HE’S A MIDDLE-AGED STEMI-PCI PATIENT. HE’S A FATHER.
AND PEOPLE ARE COUNTING ON HIM.

HELP PROTECT HIM FROM ANOTHER EVENT

REFERENCES:
1. O’Connell S, ÓLaighin G, Kelly L, et al. PLoS
One 2016;11:e0154956.
2. Evenson KR, Goto MM, Furberg RD. Int J
Behav Nutr Phys Act 2015;12:159.
3. Yang CH, Maher JP, Conroy DE. Am J Prev
Med 2015;48:452-5.
4. Totten AM, Womack DM, Eden KB, et
al. Telehealth: Mapping the Evidence for
Patient Outcomes From Systematic Reviews.
Technical Brief No. 26. AHRQ Publication
No.16-EHC034-EF. Rockville, MD: Agency
for Healthcare Research and Quality; June
2016.

20 CardioSource WorldNews

Learn more at EffientHCP.com

Effient and the Effient logo are registered trademarks of Eli Lilly and Company.
© Daiichi Sankyo, Inc. and Lilly USA, LLC 02/2016. All Rights Reserved.
PGHCPISI03Oct2011 PP-PG-US-0891.

®